Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00017381

Public ClinicalTrials.gov record NCT00017381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 17, 2026, 8:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Dose Finding Study of IDEC-Y2B8 With Autologous Stem Cell Support

Study identification

NCT ID: NCT00017381
Recruitment status: Completed
Study type: Interventional
Phase: Early Phase 1
Lead sponsor: National Cancer Institute (NCI); NIH
Enrollment: 30 participants

Conditions and interventions

Conditions

Interventions

cyclophosphamide Drug
filgrastim Biological
peripheral blood stem cell transplantation Procedure
rituximab Biological
yttrium Y 90 ibritumomab tiuxetan Radiation

Drug · Biological · Procedure + 1 more

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 31, 2001
Primary completion: Nov 30, 2007
Completion: Not listed
Last update posted: Jan 8, 2013

Started 2001

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Johns Hopkins University	Baltimore	Maryland	21287-8936	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00017381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 8, 2013 · Synced May 17, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00017381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →